Picture of Propanc Biopharma logo

PPCB Propanc Biopharma Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Propanc Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.0020.0670.0020.0040.01
Net Total Receivables0.0050.0020.0040.0020.003
Prepaid Expenses
Total Current Assets0.0910.0690.0070.0150.019
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0080.0270.0040.0650.039
Other Long Term Assets
Total Assets0.1020.0990.0130.0820.06
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities4.43.743.083.063.16
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities4.43.743.083.113.18
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity-4.3-3.64-3.07-3.02-3.12
Total Liabilities & Shareholders' Equity0.1020.0990.0130.0820.06
Total Common Shares Outstanding
Total Preferred Shares Outstanding
0